Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelo fi brosis
暂无分享,去创建一个
M. Konopleva | Z. Estrov | G. Garcia-Manero | J. Cortes | S. Verstovsek | T. Kadia | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | C. Bueso-Ramos | U. Popat | N. Pemmaraju | N. Jain | B. Carter | L. Masarová | M. Ohanian | P. Mak | P. Bose | Lingsha Zhou | S. Bledsoe | W. Qiao | Xuemei Wang | C. Bueso‐Ramos